Beneficial ownership — 13D / 13G
87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Great Hill Equity Partners IV, L.P. | INTA Intapp, Inc. | 13D/A | 19.6% | Nov 14, 2023 | 3y |
| Timothy A. Springer | RNAC Cartesian Therapeutics, Inc. | 13D/A | 27.7% | Nov 13, 2023 | 3y |
| Timothy Hwang | NOTE FiscalNote Holdings, Inc. | 13D/A | 7.98% | Nov 9, 2023 | 3y |
| Cannae Holdings, Inc. | SST System1, Inc. | 13D/A | 28.6% | Nov 9, 2023 | 3y |
| Redmile Group, LLC | RGNX REGENXBIO Inc. | 13G | 9.6% | Nov 9, 2023 | 3y |
| Hill City Capital, LP | ARRY Array Technologies, Inc. | 13G | 5.14% | Nov 9, 2023 | 3y |
| Notch View Capital Management, LLC | FREE Whole Earth Brands, Inc. Class A Common Stock | 13G | 5.2% | Nov 9, 2023 | 3y |
| AH Bio Fund II, L.P. | EQRX EQRx, Inc. Common Stock | 13D/A | 0% | Nov 9, 2023 | 3y |
| Millennium Management LLC | MXCT Maxcyte, Inc. | 13G | 5.6% | Nov 8, 2023 | 3y |
| Mork Capital Management, LLC | NSFDF NXT Energy Solutions Inc. | 13D/A | 24.48% | Nov 8, 2023 | 3y |
| Jason Zhang | APLD Applied Digital Corp. | 13D | 6.8% | Nov 7, 2023 | 3y |
| Gene Salkind | MOBQ Mobiquity Technologies, Inc. | 13D/A | 60.2% | Nov 7, 2023 | 3y |
| D. E. Shaw & Co., L.P. | AAP Advance Auto Parts Inc | 13G | 5% | Nov 7, 2023 | 3y |
| Alan B. Levan | BVH Bluegreen Vacations Holding Corporation | 13D/A | 42% | Nov 5, 2023 | 3y |
| John E. Abdo | BVH Bluegreen Vacations Holding Corporation | 13D/A | 19% | Nov 5, 2023 | 3y |
| Platanus Investment LLC | KRRO Korro Bio, Inc. | 13G | 6.8% | Nov 3, 2023 | 3y |
| New Enterprise Associates 17, L.P. | KRRO Korro Bio, Inc. | 13D | 13.4% | Nov 3, 2023 | 3y |
| Activision Publishing, Inc. | MYPS PLAYSTUDIOS, Inc. | 13G/A | 10.8% | Oct 13, 2023 | 3y |
| DCM Ventures China Fund (DCM VIII), L.P. ("Main Fund VIII") | HERE Here Group Ltd | 13D | 24.8% | Jan 24, 2023 | 3y |
| Ned L. Sherwood | BRN Barnwell Industries Inc | 13D/A | 27.39% | Nov 16, 2023 | 3y |
| General Electric Co | AER AerCap Holdings N.V. | 13D/A | 0% | Nov 16, 2023 | 3y |
| Point72 Asset Management, L.P. | LYRA Lyra Therapeutics, Inc. | 13G | 5.4% | Nov 15, 2023 | 3y |
| BROOKFIELD Corp /ON/ | BEP Brookfield Renewable Partners L.P. | 13D/A | 47.4% | Nov 15, 2023 | 3y |
| Apollo Management Holdings GP, LLC | EGIO Edgio, Inc. Common Stock | 13D/A | 35.8% | Nov 14, 2023 | 3y |
| FS Capital Partners VI, LLC | ARHS Arhaus, Inc. | 13D/A | 23.09% | Nov 14, 2023 | 3y |
| AstraZeneca PLC | CLLS Cellectis S.A. | 13D/A | 22.4% | Nov 14, 2023 | 3y |
| Saba Capital Management, L.P. | ASA ASA Gold & Precious Metals Ltd | 13D/A | 12.45% | Nov 14, 2023 | 3y |
| David Seldin | BURU Nuburu, Inc. | 13D/A | 34% | Nov 13, 2023 | 3y |
| GIP II Blue Holding, L.P. | HESM Hess Midstream LP | 13D/A | 52.2% | Nov 13, 2023 | 3y |
| Jay Lichter, Ph.D. (Lichter) | JANX Janux Therapeutics, Inc. | 13D/A | 21.2% | Nov 13, 2023 | 3y |
| WHITMORE BRADFORD T | SLSN Solesence, Inc. | 13D/A | 62.4% | Nov 13, 2023 | 3y |
| Hess Investments North Dakota LLC | HESM Hess Midstream LP | 13D/A | 56% | Nov 13, 2023 | 3y |
| Johnson & Johnson Innovation - JJDC, Inc. | NBTX Nanobiotix S.A. | 13G | 10.2% | Nov 9, 2023 | 3y |
| Engaged Capital LLC | BRCC BRC Inc. | 13D/A | 20.6% | Nov 9, 2023 | 3y |
| MILLENNIUM MANAGEMENT LLC | ENTA Enanta Pharmaceuticals Inc | 13G | 4.9% | Nov 7, 2023 | 3y |
| Flawless Management Inc. | CISS C3is Inc. | 13D | 9.97% | Nov 6, 2023 | 3y |
| Baldo Fodera | ASTR Astra Space, Inc. Class A Common Stock | 13D | 9.99% | Nov 6, 2023 | 3y |
| Cormorant Asset Management, LP | KRRO Korro Bio, Inc. | 13G | 8.49% | Nov 6, 2023 | 3y |
| Steamboat Capital Partners, LLC | WHLR Wheeler Real Estate Investment Trust, Inc. | 13D | 0.2% | Nov 6, 2023 | 3y |
| GLOBAL VALUE INVESTMENT CORP. | FLNT Fluent, Inc. | 13D | 5.1% | Nov 6, 2023 | 3y |
| Polar Capital Holdings Plc | ARQT Arcutis Biotherapeutics, Inc. | 13G | 7.56% | Oct 20, 2023 | 3y |
| Qing Cai HUANG | NWGL CL Workshop Group Ltd | 13D | 5.7% | Oct 9, 2023 | 3y |
| Wing Luk CHAN | NWGL CL Workshop Group Ltd | 13D | 5.7% | Oct 9, 2023 | 3y |
| Lin Li | NCL Northann Corp. | 13D | 73.65% | Sep 29, 2023 | 3y |
| SIT INVESTMENT ASSOCIATES INC | KTF Dws Municipal Income Trust | 13D/A | 11.32% | Nov 15, 2023 | 3y |
| SIT INVESTMENT ASSOCIATES INC | NHS Neuberger High Yield Strategies Fund Inc. | 13G/A | 4.42% | Nov 15, 2023 | 3y |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | TDF Templeton Dragon Fund Inc | 13D | 36.2% | Nov 14, 2023 | 3y |
| GAMCO INVESTORS, INC. ET AL | GYRO Gyrodyne, LLC | 13D/A | 9.47% | Nov 14, 2023 | 3y |
| ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | CMMB Chemomab Therapeutics Ltd. | 13D/A | 18.3% | Nov 14, 2023 | 3y |
| Praesidium Investment Management Company, LLC | ZUO Zuora, Inc. | 13D/A | 4.9% | Nov 14, 2023 | 3y |